2012年9月7日星期五

UK cost agency reconsiders snub for GSK lupus drug

LONDON, Sept 7 (Reuters) - Britain's healthcare cost
watchdog NICE said on Friday it was reconsidering a decision to
recommend against use of GlaxoSmithKline's lupus drug
Benlysta on the state health service, following an appeal by the
drugmaker.

structured settlements and periodic payment judgments structured settlements company cheap car insurance sydney

没有评论:

发表评论